Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 6:05 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 1,484 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Head and Neck Neoplasms
Interventions: Software Solution for Radiation Therapy Treatment, Radiation therapy; Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Glioblastoma
Interventions: Depatuxizumab mafodotin, Temozolomide, Lomustine; Drug
Lead sponsor: AbbVie; Industry
Eligibility: Up to 99 Years
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 13
States / cities: Palo Alto, California • Aurora, Colorado • Denver, Colorado + 9 more

Conditions: Hearing Loss
Interventions: Distortion product otoacoustic emissions (DPOAE); Diagnostic Test
Lead sponsor: Gateway Biotechnology, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Solid Tumors, Central Nervous System Tumors
Interventions: Vinblastine and Sirolimus; Drug
Lead sponsor: The Hospital for Sick Children; Other
Eligibility: Up to 21 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 3
States / cities: San Diego, California • St Louis, Missouri • Burlington, Vermont

Conditions: Telemetry, Patient Monitoring
Interventions: Vital Sync IM & VPMP (Surveillance Monitoring), Telemetry Monitoring; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypertension
Interventions: carvedilol; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 80 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Lymphopenia
Interventions: nogapendekin-alfa inbakicept; Drug
Lead sponsor: ImmunityBio, Inc.; Industry
Eligibility: 18 Years and older
U.S. locations: 1
States / cities: El Segundo, California

Conditions: Smoking Cessation, Smoking, Smoking Reduction, Smoking, Cigarette, Smoking (Tobacco) Addiction, Smoking Habit
Interventions: Guided Imagery Intervention, Standard Behavioral Control; Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 1,209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Ebola Virus Disease, Marburg Virus Disease
Interventions: cAd3-Marburg, cAd3-EBO-S; Biological
Lead sponsor: Albert B. Sabin Vaccine Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Endometrial Cancer
Interventions: Carboplatin and Paclitaxel, Radiation Therapy; Drug · Radiation
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Marywood, Illinois

Conditions: Diabetes Mellitus, Type 1
Interventions: Closed Loop with Pramlintide; Device
Lead sponsor: University of Virginia; Other
Eligibility: 21 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Advanced Multiple Myeloma
Interventions: Filanesib, KSP (Eg5) inhibitor; intravenous, Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 29
States / cities: Birmingham, Alabama • Duarte, California • San Francisco, California + 24 more

Conditions: Transitional Cell Carcinoma of Bladder, Superficial Bladder Cancer
Interventions: Hyperthermia System, Mitomycin C; Device · Drug
Lead sponsor: Mark Dewhirst; Other
Eligibility: 18 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Distal Radius Fracture, Rehabilitation
Interventions: occlusion training with tourniquet (DELFI PTS ii portable tourniquet system); Device
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Liver Diseases, Liver Cirrhosis, NASH (Non-Alcoholic Steatohepatitis)
Interventions: Comprehensive Palliative Care services, Usual hepatic care; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Post Operative, Post Operative Analgesia, Urogynecologic Surgery
Interventions: Tizanidine, Standard-of-Care Therapy; Drug · Other
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Delayed Post-Polypectomy Induced Ulcer Hemorrhage
Interventions: Doppler Endoscopic Probe; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 35 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 3
States / cities: Downey, California • Los Angeles, California • West Los Angeles, California

Conditions: Uterine Injury
Interventions: MRI, SWE, and US evaluation; Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Femoral Shaft Fracture, Tibial Shaft Fracture
Interventions: GIK solution, Isotonic Normal Saline Solution; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Esophageal Cancer, Lung Cancer
Interventions: cone-beam CT; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Invasive Candidiasis
Interventions: Preemptive Therapy with Anidulafungin, Empiric antifungal therapy based on physician discretion.; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Bone Marrow, Stem Cell Transplant
Interventions: Massage Therapy, Humor Therapy, Relaxation Therapy; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 6 Years to 18 Years
Enrollment: 189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 3
States / cities: Columbus, Ohio • Philadelphia, Pennsylvania • Memphis, Tennessee

Conditions: Intellectual Disability, Variable
Interventions: Pre-Dental Telehealth (PDT); Behavioral
Lead sponsor: Boston University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Antineoplastic Agents
Interventions: weekly telephone follow up, usual care; Behavioral
Lead sponsor: Bassett Healthcare; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Cooperstown, New York

Search by objective public record fields.

Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Hearing Changes After Surgery

Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours

Surveillance Monitoring as an Alternative to Telemetry

Conditioned Pharmacotherapeutic Effects in Hypertension

Expanded Access Use of Nogapendekin-alfa Inbakicept in the Reversal and Maintenance of Absolute Lymphocyte Count (ALC) for the Treatment of Lymphopenia Induced by Chemotherapy, Immunotherapy, and/or Radiation Therapy

Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes Mellitus

A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)

Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer

BFR DISTRAD: Blood Flow Restricted Training During Rehabilitation Following Distal Radius Fracture Repair

Palliative Care for Non-Malignant Diseases (COMPASS Trial)

Postoperative Tizanidine Use in Pelvic Reconstructive Surgery: A Pilot Study

Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding

A Novel Imaging Modality to Evaluate Radiation-Induced Uterine Injury

MAGIK for Femoral/Tibial Shaft Fractures

Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer

β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients

Testing the Effectiveness of Child and Parent-Targeted Health Promotion Interventions in Pediatric Stem Cell Transplantation

A Pilot Project to Facilitate Dental Care and Reduce Barriers For Youth With Disabilities

Does a Nursing Intervention Improve Adherence to Oral Chemotherapies in the Outpatient Cancer Treatment Setting?